Oberweis Asset Management’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.9M Buy
388,194
+45,800
+13% +$1.85M 0.37% 99
2026
Q1
$11.3M Buy
342,394
+6,194
+2% +$201K 0.34% 108
2025
Q4
$11M Buy
336,200
+8,100
+2% +$199K 0.4% 97
2025
Q3
$5.85M Hold
328,100
0.22% 138
2025
Q2
$3.56M Buy
328,100
+27,600
+9% +$362K 0.15% 154
2025
Q1
$5.56M Hold
300,500
0.28% 123
2024
Q4
$4.95M Buy
300,500
+72,500
+32% +$1.03M 0.23% 141
2024
Q3
$3.2M Buy
+228,000
New +$2.52M 0.16% 168
2024
Q2
Sell
-286,400
Closed -$2.31M 198
2024
Q1
$2.31M Buy
+286,400
New +$2.56M 0.17% 164
2018
Q1
Sell
-11,200
Closed -$317K 225
2017
Q4
$317K Sell
11,200
-4,700
-30% -$111K 0.07% 201
2017
Q3
$308K Hold
15,900
0.09% 132
2017
Q2
$266K Sell
15,900
-5,100
-24% -$68.8K 0.07% 124
2017
Q1
$219K Buy
+21,000
New +$214K 0.06% 132

Other funds holding AXGN

Oberweis Asset Management's AXGN Position: Q2 2026 in Review

Oberweis Asset Management increased its Axogen (AXGN) stake by 13% in Q2 2026, buying an estimated $1.85M and bringing the position to 388,194 shares worth $17.9M. The position accounts for 0.37% of the portfolio, ranked #99.

Oberweis Asset Management first reported a position in AXGN in Q1 2017 and has held it in 13 quarters since. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • Oberweis Asset Management held 388,194 shares of Axogen worth $17.9M as of Q2 2026.
  • Oberweis Asset Management bought 45,800 Axogen shares in Q2 2026, an estimated $1.85M.
  • Axogen made up 0.37% of Oberweis Asset Management's portfolio in Q2 2026, its #99 holding.
  • Oberweis Asset Management first reported a position in Axogen in Q1 2017 and has held it in 13 quarters since.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Oberweis Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.